References
- Lu X, Chang R. Polycythemia Vera. [Updated 2023 Apr 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024; Available at: https://www.ncbi.nlm.nih.gov/books/NBK557660/
- Tefferi A, Barbui T. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023; 98(9): 1465-1487.
- Tefferi A, Vannucchi AM, Barbui T. Polycythemia vera: historical oversights, diagnostic details, and therapeutic views. Leukemia. 2021; 35(12):3339-3351.
- Tefferi A, Vannucchi AM, Barbui T. Polycythemia vera treatment algorithm 2018. Blood Cancer J. 2018; 8(1):3.
- Benevolo G, Marchetti M, Melchio R et colab. Diagnosis and Management of Cardiovascular Risk in Patients with Polycythemia Vera. Vasc Health Risk Manag. 2023; 19:765-778.
- Akdi A, Özeke Ö, Karanfil M et colab. Diurnal rhythm of blood pressure in patients with polycythemia vera. Blood Press Monit. 2020; 25(2):69-74.
- Umer W, Umer N, Ali EA, Abubakar M, Yassin MA. Polycythemia Vera With Atrial Fibrillation: A Case Report and Review of the Literature. Cureus. 2022; 14(8):e28550.
- Găman MA, Srichawla BS, Chen YF et colab. Overview of dyslipidemia and metabolic syndrome in myeloproliferative neoplasms. World J Clin Oncol. 2024; 15(6):717-729.
- Wakabayashi I. Effects of age on polycythemia, cardiometabolic risk and their associations in middle-aged men. J Diabetes Metab Disord. 2022; 22(1):287-295.
- Visweshwar N, Fletcher B, JaglalMet colab. Impact of Phlebotomy on Quality of Life in Low-Risk Polycythemia Vera. J Clin Med. 2024; 13(16):4952.